Brigatinib 90mg-180mg ALK NSCLC Generic Tablets

So, Brigatinib is this special kind of drug that targets something called the Anaplastic Lymphoma Kinase. It’s mainly used to treat a specific type of lung cancer that has spread to other parts of the body. It does its thing by kind of jamming up this signaling process involving the ALK stuff.

It’s available in different tablet sizes — 30, 90, and 180 mg. You start with a 90 mg pill every day for the first week, then you step it up to the big 180 mg dose. Each bottle has 30 tablets in it.

The therapeutic approach primarily targets cancer cells exhibiting an alteration in the ALK gene that promotes cancer growth, thereby limiting the growth and spread of tumor cells in patients diagnosed with ALK-positive NSCLC.